KORU Medical Systems: Innovating Subcutaneous Infusion for Enhanced Patient Care and Quality of Life

KORU Medical Systems: Advancing Subcutaneous Infusion Solutions

KORU Medical Systems, based in Mahwah, N.J., is at the forefront of medical technology innovation, focusing on subcutaneous infusion solutions that significantly enhance patient quality of life. The company is recognized for its pioneering FREEDOM Syringe Infusion System, which includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, along with Precision Flow Rate Tubing™ and the HIgH-Flo Subcutaneous Safety Needle Sets™. This system, which received its first FDA clearance in 1994, empowers patients to self-administer their medications comfortably at home or receive treatments in ambulatory infusion centers under the supervision of healthcare professionals. KORU Medical's dedication to developing user-friendly, effective solutions positions it as a leader in the evolving landscape of patient-centric care.

The company’s emphasis on innovation extends beyond its existing product lines. Through its Novel Therapies division, KORU Medical actively collaborates with biopharmaceutical companies to support clinical trials and drug development. By providing customizable infusion solutions that accommodate various drug categories, KORU Medical helps streamline the development process for new therapies. This strategic approach not only reinforces the company’s commitment to enhancing the patient experience but also ensures that it remains a vital partner in the medical technology ecosystem, particularly as the demand for at-home healthcare solutions continues to rise.

KORU Medical Systems is also making its mark in the investor landscape, participating in two notable conferences in November 2024: the 15th Annual Craig-Hallum Alpha Select Conference and the Canaccord MedTech, Diagnostics, and Digital Health & Services Forum. These events will provide KORU Medical with opportunities to showcase its innovative solutions and engage with stakeholders, further solidifying its presence in the industry. As the company continues to grow, its focus on developing effective subcutaneous infusion technologies and fostering partnerships within the biopharmaceutical sector highlights its commitment to improving healthcare delivery and patient outcomes.

In addition to its innovative products, KORU Medical Systems maintains an open line of communication with its stakeholders. The company encourages interested individuals to visit its website at www.korumedical.com for more information on its offerings and developments. As KORU Medical continues to push the boundaries of medical technology, it remains dedicated to its mission of enhancing the quality of life for patients worldwide.